摘要
中国高尿酸血症(HUA)患病率逐年增高,已成为仅次于糖尿病的第二大代谢性疾病。血尿酸升高除引起痛风之外,还与肾脏、内分泌代谢、心脑血管等系统疾病的发生和发展有关。共识在《中国高尿酸血症相关疾病诊疗多学科专家共识》(2017版)基础上,由风湿免疫、肾脏、内分泌代谢、心血管、神经、泌尿、营养、儿科、老年、药学、影像、血液肿瘤、呼吸、重症、中医学和病理共16个学科专家共同更新、修订而成,旨在持续推动全国各相关学科对HUA相关疾病的认识,规范和指导其临床实践,改善患者预后,为相关学科的各级临床医师提供参考。
The prevalence of hyperuricemia(HUA)in China has been increasing year by year and it has stepped up to the second most common metabolic disease following diabetes mellitus.Besides gout,HUA is also related to the occurrence and development of kidney,endocrine metabolism,cardiovascular and cerebrovascular diseases.The expert consensus is based on Chinese multi-disciplinary consensus on the diagnosis and treatment of HUA and its related diseases in 2017,which was updated and revised by rheumatologists,nephrologists,endocrinologists,cardiologists,neurologists,urologists,nutritionists,pediatrians,gerontologists,pharmacists,radiologists,oncologists,respiratory physicians,critical medicine specialists,traditional Chinese medicine specialists and pathologists.The consensus aims to continuously promote the knowledge of HUA-related diseases in all relevant disciplines,standardize and guide clinical practice and improve the prognosis of patients,and provide references for clinicians from related disciplines at all levels.
出处
《中国实用内科杂志》
CSCD
北大核心
2023年第6期461-480,共20页
Chinese Journal of Practical Internal Medicine
基金
上海市申康医院发展中心重大临床研究项目(SHDC2020CR1013B)。
关键词
高尿酸血症
高尿酸血症相关疾病
诊断
治疗
专家共识
hyperuricemia
hyperuricemia-related diseases
diagnosis
treatment
expert consensus
